Lichen planopilaris is a variant of lichen planus that affects the scalp, resulting in perifollicular erythema and scarring of cutaneous surfaces accompanied by hair loss. There is no known cause of lichen planus, and it is an inflammatory disorder of the skin and mucous membranes.
There are no specific product details mentioned in the search results for lichen planopilaris. However, some studies have investigated the use of antioxidant therapies in the treatment of lichen planus. Oral antioxidant supplementation and topical antioxidant therapy have been studied as potential treatments for lichen planus.
Positive aspects of treatment for lichen planus include the use of drugs such as acitretin, griseofulvin, hydroxychloroquine, and narrow band ultraviolet B, which have been demonstrated to be effective in the treatment of cutaneous lichen planus. Additionally, a randomized, double-blind, crossover study found that topical tocopherol was effective in the treatment of reticular oral lichen planus.
Negative aspects of treatment for lichen planus include the unfavorable safety profile of sulfasalazine, which is effective in treating cutaneous lichen planus. Evidence from large-scale randomized trials demonstrating the safety and efficacy for many other treatment modalities used to treat cutaneous lichen planus is simply not available.
In conclusion, there are no specific product details mentioned in the search results for lichen planopilaris. However, some studies have investigated the use of antioxidant therapies in the treatment of lichen planus. Positive aspects of treatment include the use of drugs such as acitretin, griseofulvin, hydroxychloroquine, and narrow band ultraviolet B, while negative aspects include the unfavorable safety profile of sulfasalazine.
